MCM
HALO icon

MAI Capital Management’s Halozyme HALO Stock Holding History

MAI Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
3,026
+2,132
+238% +$145K ﹤0.01% 1720
2026
Q1 		$57.8K Buy
894
+710
+386% +$50.1K ﹤0.01% 2150
2025
Q4 		$12.4K Sell
184
-69
-27% -$4.64K ﹤0.01% 2756
2025
Q3 		$18.6K Buy
253
+4
+2% +$266 ﹤0.01% 2431
2025
Q2 		$13K Buy
249
+17
+7% +$967 ﹤0.01% 2589
2025
Q1 		$14.8K Buy
232
+77
+50% +$4.47K ﹤0.01% 2310
2024
Q4 		$7.41K Buy
+155
New +$7.95K ﹤0.01% 2636

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

MAI Capital Management's HALO Position: Q2 2026 in Review

MAI Capital Management increased its Halozyme (HALO) stake by 238% in Q2 2026, buying an estimated $145K and bringing the position to 3,026 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

MAI Capital Management first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • MAI Capital Management held 3,026 shares of Halozyme worth $237K as of Q2 2026.
  • MAI Capital Management bought 2,132 Halozyme shares in Q2 2026, an estimated $145K.
  • Halozyme made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1720 holding.
  • MAI Capital Management first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.